Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Editorial: B-cell engineering in malignant and non-malignant disease

  • Lucia Sereni1,2,3
  • Valentina Capo4,5
  • Francesca Pala6
6 affiliations
  1. 1Dana-Farber Cancer Institute, Pediatric Oncology
  2. 2Boston Children’s Hospital, Hematology/Oncology Division
  3. 3Harvard Medical School
  4. 4San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute
  5. 5Milan Unit, Institute of Genetic and Biomedical Research, Consiglio Nazionale delle Ricerche
  6. 6National Institute of Allergy and Infectious Diseases (NIH)
Open at sourcePDFDOICite

Related

  1. Editorial: Advancing enteric disease treatments: probiotics and antimicrobial strategies
    Vijay Morampudi
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref
  2. Editorial: Exploring AI’s role in disease prediction and diagnosis through medical big data
    Yulin Zhang
    Frontiers in Molecular BiosciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationGeneral biologyDOAJ
  3. Editorial: Advancing plant histopathology: unraveling plant-pathogen interactions and disease resistance mechanisms
    João Paulo Rodrigues Marques, Mariana Patanita
    Frontiers in Plant SciencePeer-reviewedCC BY 4.0Plant biologyCrossref
  4. Editorial: Smart plant pest and disease detection machinery and technology: innovations for sustainable agriculture
    Xing Yang, Fan Yang
    Frontiers in Plant SciencePeer-reviewedCC BY 4.0Plant biologyCrossref
  5. Editorial Note: C4b Binding Protein Binds to CD154 Preventing CD40 Mediated Cholangiocyte Apoptosis: A Novel Link between Complement and Epithelial Cell Survival
    The PLOS One Editors
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyPLOS

Cite

BibTeXRIS
BibTeX
@article{sereni2026editorial,
  title = {{Editorial: B-cell engineering in malignant and non-malignant disease}},
  author = {Lucia Sereni and Valentina Capo and Francesca Pala},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.2014160},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2014160/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Editorial: B-cell engineering in malignant and non-malignant disease
AU  - Lucia Sereni
AU  - Valentina Capo
AU  - Francesca Pala
PY  - 2026
DA  - 2026/10/09
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.2014160
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2014160/full
SN  - 1664-3224
ER  -